Viral diseases and the
presence of pathogens
Diagnosis and treatment
In addition to oncological tests, in cooperation with R.G.C.C. Laboratories we also offer tests for the presence of viruses.
PaldiSpot TEST
The PaldiSpot test detects the presence of Borrelia, Babesia and Bartonella genospecies in the patient's DNA.
The PaldiSpot test, analyzing DNA extracted from the patient's blood cells and blood serum, enables detection of the presence of 23 of the most common species of Borrelia, Babesia and Bartonella.
PrimeSpot TEST
The PrimeSpot test detects and determines the amount of specific viruses and different types of Lyme disease in a patient's DNA sample.
When used in conjunction with our PaldiSpot test, the PrimeSpot test provides the necessary information to develop an individual treatment and therapy of Lyme disease and Chronic Fatigue Syndrome (CFS).
PrediSpot TEST
The PrediSpot test, analyzing the patient's DNA, detects genetic characteristics that lead to the development of diseases such as Alzheimer's disease, Asthma, Coronary artery disease, Crohn's disease, Multiple sclerosis, Osteoporosis, Rheumatoid arthritis, Systemic Lupus, Thrombosis and Diabetes Type 1 and 2.
SNPs TEST
The SNPs test, analyzing the patient's DNA, determines how the patient will react to treatment with the most common anti-inflammatory, antibiotic and anticoagulant drugs. The personalized profile we receive provides the necessary information when and how to apply adequate drugs and treatments in relation to the patient's current condition.
Viral disease
treatment
Viral diseases or infections are caused by viruses and can appear as local inflammation or as a systemic disease. Very often, after the incubation period, they manifest as a short-term illness with general symptoms. Viruses can stay in the body in a latent form for years without major consequences or cause a lifelong chronic infection and multiply constantly, despite the patient's defense mechanisms. An important role in the development of a viral infection is played by the sensitivity of the cell to the virus. By multiplying inside the cell, it can interfere with its metabolism and cause its death, it can change the properties of the cell and thus lead to the change of the cell from normal to malignant, or it can multiply without disrupting the function of the cell. Viruses can cause damage to many organic systems of the peripheral nervous system, digestive system, liver, pancreas, heart and blood flow, immune system, skin, mucous membrane, urinary system, sexual organs. Many viruses have oncogenic properties and are associated with the formation of some tumors (eg human papillomavirus, Epstein-Barr virus, hepatitis B and C virus).
Q-REstrain Virus and Pathogens therapy consists of microRNA molecules with the ability to regulate the gene expression of a specific target. The short dsRNAs (double-stranded RNAs) are derived by cleavage of long dsRNA from Dicer and can be microRNAs (miRNAs). miRNAs then assemble with RNA-induced silencing complex (RISC) and cause gene silencing. RNAi has been used in the therapy of different diseases like viral infections, respiratory diseases, etc. Targeting of specific proteins, through degradation of their mRNA, is very common in treatments of different types of viral, pathogens and other infections.
Q-REstrain contains microRNAs isolated by the patient’s sample, leading to the degradation of specific mRNA molecules, which are overexpressed in this specific sample, thus regulating the expression.
With this therapies we can target:
I. Virus Antagonist Q-Restrain therapy
• Citomegalovirus (CMV)
• Coxsackie
• Epstein Barr (EBV)
• Hepatatis B & C (HBV, HCV)
• Human Simplex Virus (HHV1/HSV1)
• Human Immunodeficiency virus AIDS (HIV)
• Human T-cell Lymphotropic virus (HTLV1)
• Human Simplex Virus (HHV2/HSV2)
• A & B Human Herpes Virus (HHV6)
• Varicella Zoster Shingles Virus (VZV)
II. HPV (Human Papilloma Virus) Q-Restrain therapy
• HPV 6, HPV 11, HPV 16, HPV 18
III. Lyme Disease Q-Restrain Therapy (LyD – Borellia + Babesia)
• Ba. Bovis
• Ba. Divergens
• Ba. Duncani
• Ba. Microti
• Ba. Odocoilei
• Ba. Species
• Ba. Bigemina
• Bo. Afzelii
• Bo. Bavariensis
• Bo. Bissettii
• Bo. Burgodorferi
• Bo. Californiensis
• Bo. Finlandensis
• Bo. Garinii
• Lyme Disease
• Bo. Genomospecies
• Bo. Hermsii
• Bo. Kurtenbachii
• Bo. Lusitaniae
• Bo. Mayonii
• Bo. Miyamotoi
• Bo. Recurrentis
• Bo. Sinica
• Bo. Turcica
• Bo. Turicatae
• Bo. Valaisiana
• Bo. Yangtzensis
• Can. Bo. Tachyglossi
IV. Bartonella Q-Restrain Therapy (Brt – Lyme disease)
• B. Bacilliformis
• B. Henselae
• B. Koehierae
• B. Quintana
• B. Species
V. Other Tick-Borne Bacterial diseases Q-Restrain Therapy
• Anaplasma phacocytophilum
• Ehrlichia chaffeensis
• Rickettsia rickettsii
Q-REstrain is for autologous use only and is provided through the RGCC network.